120 related articles for article (PubMed ID: 9884813)
1. An endoscopic photographic comparison of nasal drug delivery by aqueous spray.
Homer JJ; Raine CH
Clin Otolaryngol Allied Sci; 1998 Dec; 23(6):560-3. PubMed ID: 9884813
[TBL] [Abstract][Full Text] [Related]
2. The effect of inferior turbinate hypertrophy on nasal spray distribution to the middle meatus.
Dowley AC; Homer JJ
Clin Otolaryngol Allied Sci; 2001 Dec; 26(6):488-90. PubMed ID: 11843929
[TBL] [Abstract][Full Text] [Related]
3. A study of intranasal distribution of azelastine hydrochloride aqueous nasal spray with different spray techniques.
Bateman ND; Whymark AD; Clifton NJ; Woolford TJ
Clin Otolaryngol Allied Sci; 2002 Oct; 27(5):327-30. PubMed ID: 12383290
[TBL] [Abstract][Full Text] [Related]
4. Moderate leukocyte infiltration in the lower turbinate mucosa after a two-week intranasal administration of mometasone furoate, azelastine or salmon calcitonin.
Vera-Cruz P; Ferreira M; Zagalo C; dos Santos MJ; Aguas AP
Rev Laryngol Otol Rhinol (Bord); 2009; 130(2):105-9. PubMed ID: 19813472
[TBL] [Abstract][Full Text] [Related]
5. Intranasal spray medications for maintenance therapy of allergic rhinitis.
Berger WE; Meltzer EO
Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
[TBL] [Abstract][Full Text] [Related]
6. The delivery of topical nasal sprays and drops to the middle meatus: a semiquantitative analysis.
Tsikoudas A; Homer JJ
Clin Otolaryngol Allied Sci; 2001 Aug; 26(4):294-7. PubMed ID: 11559340
[TBL] [Abstract][Full Text] [Related]
7. The effect of middle turbinate resection on topical drug distribution into the paranasal sinuses.
Halderman AA; Stokken J; Sindwani R
Int Forum Allergy Rhinol; 2016 Oct; 6(10):1056-1061. PubMed ID: 27255595
[TBL] [Abstract][Full Text] [Related]
8. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
Berger W; Hampel F; Bernstein J; Shah S; Sacks H; Meltzer EO
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
[TBL] [Abstract][Full Text] [Related]
9. Nasal gel and olfactory cleft.
Herranz González-Botas J; Padín Seara A
Acta Otorrinolaringol Esp; 2012; 63(5):370-5. PubMed ID: 22770867
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber.
Kyrein HJ; Horak F; Nirnberger G; Rehn D
Arzneimittelforschung; 1996 Aug; 46(8):794-9. PubMed ID: 9125281
[TBL] [Abstract][Full Text] [Related]
11. Nasal Delivery Devices: A Comparative Study on Cadaver Model.
Moffa A; Costantino A; Rinaldi V; Sabatino L; Trecca EMC; Baptista P; Campisi P; Cassano M; Casale M
Biomed Res Int; 2019; 2019():4602651. PubMed ID: 31032346
[TBL] [Abstract][Full Text] [Related]
12. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
[TBL] [Abstract][Full Text] [Related]
13. Effect of azelastine nasal spray on histamine-and allergen-induced skin wheal response in patients with allergic rhinitis.
Agarwal MK; Vijayan VK; Vermani M
J Asthma; 2008 Sep; 45(7):548-51. PubMed ID: 18773324
[TBL] [Abstract][Full Text] [Related]
14. Histamine skin test reactivity following single and multiple doses of azelastine nasal spray in patients with seasonal allergic rhinitis.
Pearlman DS; Grossman J; Meltzer EO
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):258-62. PubMed ID: 14533657
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical sprays on allergy-induced nasal obstruction in children.
Yaşar M; Uysal IÖ; Altuntaş EE; Cevit Ö; Müderris S
Kulak Burun Bogaz Ihtis Derg; 2013; 23(4):217-24. PubMed ID: 23834132
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen.
Howland WC; Amar NJ; Wheeler W; Sacks H
Int Forum Allergy Rhinol; 2011; 1(4):275-9. PubMed ID: 22287431
[TBL] [Abstract][Full Text] [Related]
17. A quantitative analysis of the intranasal delivery of topical nasal drugs to the middle meatus: spray versus drop administration.
Homer JJ; Maughan J; Burniston M
J Laryngol Otol; 2002 Jan; 116(1):10-3. PubMed ID: 11860644
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of sensory attributes of two antihistamine nasal sprays: olopatadine 0.6% and azelastine 0.1%.
Meltzer EO; Garadi R; Laforce C; Chadwick SJ; Berger WE; Gross G; Edwards MR; Crenshaw K; Wall GM
Allergy Asthma Proc; 2008; 29(6):659-68. PubMed ID: 19144261
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis.
van Bavel J; Howland WC; Amar NJ; Wheeler W; Sacks H
Allergy Asthma Proc; 2009; 30(5):512-8. PubMed ID: 19747429
[TBL] [Abstract][Full Text] [Related]
20. Recent In Vitro and In Silico Advances in the Understanding of Intranasal Drug Delivery.
Chen J; Martin AR; Finlay WH
Curr Pharm Des; 2021; 27(12):1482-1497. PubMed ID: 33183191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
